Corporate Info Research Reports Consulting News Contact Us
 

 

Free Research Reports

Complete the surveys below to get free findings from each study!

All Current Studies

Strategic Pricing

Brand Development & Launch

Clinical Outsourcing Cost Management
   & Decision Making

Consulting Services

Let Cutting Edge Information help you build revenues, reduce costs, and increase efficiency.

Call Jason Richardson at 919-403-6583 today to learn more about our customized research and get a free quote.

 

Managed Markets: Pharmaceutical Reimbursement Strategy, Organizational Structure and Medicare Part D (PH77)

Purchase E-Copy Now
Download Free Report Summary

Published 2006
179 Pages
350+ Metrics
95+ Charts and Diagrams

  Overview

Companies Metrics Content

Call Oveda Slade at 919-403-6583 to ask questions and learn more about managed markets departmental structure and reimbursement strategy.
Charts and Graphics
The following is a list of metrics included in this report. While this list is not inclusive of all the data in the report, it summarizes the main categories and types of data included in each chapter.

Chapter 1:

  • Percentage of companies with dedicated managed markets departments (at top-tier firms, mid-level companies and small pharmas and biotechs)
  • Percentage of companies with centralized managed markets departments
  • Functions that oversee managed markets departments
  • Number of FTEs at every level of Company U's managed markets department (including national accounts, regional accounts and marketing structures)
  • Percentage of growth expected in managed markets marketing organizations at top-tier firms in 2006 and 2008 (at the senior management, line management, line worker/analyst and administrative levels)
  • Percentage of growth expected in managed markets sales organizations at top-tier firms in 2006 and 2008 (at the senior management, account management and administrative levels)
  • Number of FTEs at every level of Company V's managed markets department (including sales, marketing, contracts and government affairs)
  • Number of FTEs at every level of Company W's managed markets department (including national accounts, regional accounts, trade relations, contract operations, government affairs and customer service)
  • Percentage of growth expected in managed markets marketing organizations at mid-size companies in 2006 and 2008 (at the senior management, line management, line worker/analyst and administrative levels)
  • Percentage of growth expected in managed markets sales organizations at mid-size companies in 2006 and 2008 (at the senior management, account management and administrative levels)
  • Company P's managed markets department structure
  • Percentage of growth expected in managed markets marketing organizations at small pharma and biotech companies in 2006 and 2008 (at the senior management, line management, line worker/analyst and administrative levels)
  • Percentage of growth expected in managed markets sales organizations at small pharma and biotech companies in 2006 and 2008 (at the senior management, account management and administrative levels)

Chapter 2:

  • Medicare Part D tiered structure
  • Number of Medicare beneficiaries with prescription drug coverage
  • Projected annual increases in Medicare Part D annual premiums, deductibles, upper limits for 75% coverage, catastrophic coverage tier levels, and coverage gaps through 2013

Chapter 3:

  • Managed markets budgets and staff for 2 products from pre-clinical development, Phase I, Phase II, Phase III, Registration & Launch Stage, Year 1 on Market, Year 2 on Market and Year 3 on Market
  • 5 companies' 2006 managed markets sales budgets (including the total number of therapeutic areas and products they support)
  • 12 companies' 2006 managed markets marketing budgets (including the total number of therapeutic areas and products they support)
  • 2006 average US managed markets marketing budgets by company size (top-tier firms, mid-size companies, and small pharmas and biotechs)
  • 2006 average US managed markets sales budgets by company size (top-tier firms, mid-size companies, and small pharmas and biotechs)
  • 10 companies' 2006 budgets for commercial managed care marketing, federal Medicare/Medicaid marketing, state Medicare/Medicaid marketing, long-term care marketing, and trade relations marketing (in real dollars and by percent of total managed markets marketing spend)
  • 5 companies' 2006 budgets for commercial managed care sales, federal Medicare/Medicaid sales, state Medicare/Medicaid sales, long-term care sales, and trade relations sales (in real dollars and by percent of total managed markets marketing spend)
  • 8 companies' 2006 managed markets marketing and sales budgets for commercial managed care, federal Medicare/Medicaid, state Medicare/Medicaid, long-term care, and trade relations
  • Employee compensation: base salary, bonus and benefits compensation for managed markets marketing and sales senior executives, line managers and line workers at small, medium and large companies


 

 

CORPORATE INFO RESEARCH REPORTS CONSULTING NEWS CONTACT US HOME
Copyright (c) Cutting Edge Information  p:919-403-6583  Please read our Copyright Policy